Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PURPOSE OF REVIEW: This brief review highlights some factors affecting the short-term and long-term outcomes after endovascular treatment (EVT) of patients with intracranial aneurysms. RECENT FINDINGS: The principal procedural risks associated with EVT are symptomatic thromboembolic events affecting 2.4-5.2% of treatments, and aneurysm perforation which occurs in 0.5-2.4% of the patients with unruptured aneurysms and 2.3-6.5% of patients with subarachnoid haemorrhage. The risk of subsequent aneurysm recurrence requiring retreatment is about 10% and does not negate the morbidity advantage (relative to surgical clipping) of the initial EVT. This risk is about three-fold greater in aneurysms with a neck width more than 4 mm and sac maximum diameter greater than 10 mm. The incidence of rebleeding after EVT is 0.11-0.32% per annum and is probably lower if EVT achieves complete occlusion. SUMMARY: EVT dramatically reduces the risk of rebleeding in patients with subarachnoid haemorrhage. Treatment risks and rates of incomplete occlusions are increased in ruptured in comparison with unruptured aneurysms. Large aneurysms have higher risk of procedural thromboembolism, incomplete treatment and rate of recurrences with strong interdependence between these variables. The low risk of rebleeding in patients with subarachnoid haemorrhage is probably increased in incompletely treated aneurysms and in patients revealing aneurysm growth over time.

Original publication




Journal article


Curr Opin Neurol

Publication Date





103 - 108


Embolization, Therapeutic, Humans, Intracranial Aneurysm, Risk Factors, Treatment Outcome